Combination therapy for reducing the risks associated with...

Details Combination therapy for reducing the risks associated with... Combination therapy for reducing the risks associated with...

A - Human Necessities

61

K

A61K 31/44 (2006.01) A61K 31/22 (2006.01) A61K 31/34 (2006.01) A61K 31/365 (2006.01) A61K 31/40 (2006.01) A61K 31/425 (2006.01) A61K 45/06 (2006.01) A61P 9/10 (2006.01) A01N 43/16 (2006.01) A01N 43/40 (2006.01)

Patent

CA 2306646

The instant invention provides a drug combination comprised of a HMG-CoA reductase inhibitor in combination with a COX-2 inhibitor, which is useful for treating, preventing, and/or reducing the risk of developing atherosclerosis and atherosclerotic disease events.

Cette invention propose une combinaison de médicaments contenant un inhibiteur de HMG-CoA réductase, associé à un inhibiteur de COX-2, servant à traiter, prévenir et/ou réduire les risques de développement de l'athérosclérose et d'apparition d'incidents pathologiques liés à l'athérosclérose.

Affiliated with

Also associated with

Rating

Combination therapy for reducing the risks associated with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy for reducing the risks associated with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for reducing the risks associated with... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1773515